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Eukaryotic EnguLfment and cell MOtility (ELMO) proteins form an evolutionary conserved family of
regulators involved in small GTPase dependent actin remodeling processes that regulates the gua-
nine exchange factor activity of some of the Downstream Of CrK (DOCK) family members. Gathered
data strongly suggest that DOCK activation by ELMO and the subsequent signaling result from a sub-
tle balance in the binding of partners to ELMO. Among its putative upward modulators, the
Hematopoietic cell kinase (Hck), a member of the Src kinase superfamily, has been identiﬁed as a
binding partner and a speciﬁc tyrosine kinase for ELMO1. Indeed, Hck is implicated in distinct mole-
cular signaling pathways governing phagocytosis, cell adhesion, and migration of hematopoietic
cells. Although ELMO1 has been shown to interact with the regulatory Src Homology 3 (SH3) domain
of Hck, no direct evidence indicating the mode of interaction between Hck and ELMO1 have been
provided in the literature. In the present study, we report convergent pieces of evidence that
demonstrate the speciﬁc interaction between the SH3 domain of Hck and the polyproline motif of
ELMO1. Our results also suggest that the tyrosine-phosphorylation state of ELMO1 tail might act
as a putative modulator of Hck kinase activity towards ELMO1 that in turn participates in DOCK180
activation and further triggers subsequent signaling towards actin remodeling.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The evolutionarily conserved signaling ELMO (EnguLfment and
cell MOtility) and DOCK (Downstream Of CrK) proteins interact to
promote the Guanine Exchange Factor (GEF) activity of DOCK in a
number of actin-dependent cellular processes [1,2]. Indeed, the
ELMO/DOCK pathway has been described as an essential signalingcascade that leads to the activation of several Rho GTPase-depen-
dent events triggering the actin cytoskeleton remodeling. Hence,
the ELMO/DOCK pathway regulates apoptotic cell engulfment by
phagocyte, but also fundamental processes such as neurite out-
growth [3], cell migration [4], cell invasion and proliferation [5],
or, for ELMO3, metastasis [6]. DOCK proteins regulate several
Rac1- and Cdc42-dependent pathways. Although the ubiquitous,
archetype of the family, DOCK180, has been shown to be sufﬁcient
to act as a GEF for Rac1 both in vitro and in cellulo [7,8], DOCK180
cooperates with ELMO for an efﬁcient Rac1 signaling in vivo [4,9–
12]. Thus, ELMO1 has been shown (i) to relieve the auto-inhibition
of DOCK180 through direct binding, (ii) to trigger DOCK180 stabi-
lization of the nucleotide free form of Rac1 [10,13], and (iii) to facil-
itate the recruitment of DOCK180 to the membrane [14,15].
Furthermore, gathered data strongly suggest that DOCK activation
and the subsequent signaling may be the result of a subtle balance
between binding of modulators to ELMO and the enhanced acces-
sibility of the GEF domain of DOCK proteins [16,17]. Among ELMO
upward modulators, RhoG, in its GTP-bound form, interacts with
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Rac1 activation [18]; Ezrin–Radixin–Moesin (ERM) familymembers
have been shown to bind ELMO and have been suggested to
contribute to the co-localization of ERM proteins and ELMO
within active GEF complexes with RhoG [19,20]; and very recently,
the receptor tyrosine kinase Axl of the Tyro3, Axl, Mer
family (TAMs) has been discovered to participate in ELMO
phosphorylation and to promote cell migration and proliferation
of breast cancer cells [5].
The Hematopoietic cell kinase (Hck), a member of the Src kinase
superfamily, has been identiﬁed as an ELMO1 partner [21]. Hck is a
tissue speciﬁc tyrosine kinase implicated in distinct molecular
signaling pathways governing several cellular processes of
hematopoietic cells, ranging from phagocytosis, cell adhesion and
migration, or lysosome functions [22–24]. Two Hck isoforms have
been described: p61Hck expression is restricted to lysosomes,
while p59Hck is membrane associated and plays a crucial role
among other regulators in actin cytoskeleton reorganization [25].
The kinase activity of p59Hck has been demonstrated to be
necessary for Rac1 and Cdc42 activation during Fcc receptor
mediated phagocytosis [26], a process that has been shown to rely
on CrkII and DOCK180 signaling [27], thus suggesting a functional
interplay between p59Hck and the ELMO/DOCK pathway.
Indeed, co-expression of Hck and ELMO1 in mammalian cell
models increases phagocytosis efﬁciency and triggers ELMO1
phosphorylation [21]. These data suggest a possible role for Hck
in the control of ELMO/DOCK dependent Rac1 activation and
actin remodeling, although its exact mechanism remains
uncharacterized.
The primary studies of ELMO1/Hck interaction have shown a
direct binding between ELMO1 and the Src Homology 3 (SH3)
domain of Hck, suggesting a possible role of the C-terminal
polyproline motif of ELMO1 in this interaction [21]. Interestingly,
co-precipitation experiments have initially shown that the
polyproline motif of ELMO1 could interact with the SH3 domain
of DOCK180 [4]. However, both the SH3 domain and the
polyproline motif are dispensable for the interaction [8] that is
then believed to rely on an extended interaction between the
C-terminal region of ELMO including the Pleckstrin Homology
(PH) domain with a N-terminal region of DOCK covering the
SH3 domain and its ﬂanking a-helices [28]. Our group further
demonstrated that the SH3 domain of DOCK180 interacts
signiﬁcantly with ELMO1, regardless of the presence of the
polyproline motif, but that the polyproline/SH3 interaction may
increase the life-time of the ELMO1/DOCK180 complex, supporting
the hypothesis that the polyproline motif of ELMO1 and the SH3
domain of DOCK180 contribute to enhance actin cytoskeleton
remodeling [29].
To date, no evidence for the direct binding between the
polyproline motif of ELMO1 and the SH3 domain of Hck has been
provided and the mode of interaction between Hck and ELMO1
remains to be identiﬁed. Here, we report evidence that, in contrast
with the SH3 domain of DOCK180, the interaction of the SH3
domain of Hck with the C-terminal domain of ELMO1 depends
on the presence of the polyproline motif.
2. Materials and methods
2.1. Cloning
The cDNA encoding the wild-type murine ELMO1 was
kindly provided by Dr. Yoshinori Fukui. Full length and truncated
forms of ELMO1 were generated by PCR (ELMO1–727, ELMO532–727,
ELMO532–707, Fig. 1) and subcloned either using ligation-indepen-dent cloning [30] in framewith a Tobacco Etch Virus (TEV) protease
cleavable 6-Histine tag for bacterial expression (pPROEXHtb) or by
conventional ligation into a modiﬁed pEGFP-N1 vector for
mammalian expression, in which the EGFP ORF is replaced by a
TEV cleavable SNAP tag (New England Biolabs). The cDNA for bacte-
rial expression encoding the SH3 domain of Hck (residues 77–141
of Uniprot Protein Database: P08631; SH3Hck) in fusion with a
PreScission (GE-Healthcare) cleavable GST tag has been gifted by
S. Feuerstein (pGEX6P2-Hck-SH3). For mammalian expression
SH3Hck coding sequence was ampliﬁed by PCR (residues 77–141)
and cloned in frame with the CLIP tag of the pCLIPf vector (New
England Biolabs) The cDNA encoding for the human SH3 domain
of DOCK180 (DOCKSH3: residues 9–69 of DOCK180 from Uniprot
Protein Database: Q14185) was optimized for bacterial expression,
synthesized (Geneart AG) and subcloned into pGEX 4T3 in frame
with a TEV cleavable GST tag for bacterial expression.
2.2. Puriﬁcation of recombinant proteins from bacteria
For bacterial production and puriﬁcation, the recombinant pro-
tein constructs were overexpressed in BL21(DE3) Escherichia coli
strain using conventional IPTG induction (1 mM) in LB medium
for 3 h at 37 C. For 6-His-tagged constructs, bacteria were lysed
using a Microﬂuidizer (Microﬂuidics) in Phosphate-Buffered Sal-
ine (PBS), supplemented with DNAse (25 lg/ml), 1 mM MgCl2
and Complete cocktail (Roche Diagnostics). The lysate was clari-
ﬁed by centrifugation and loaded on a Ni–NTA column (Qiagen).
The protein was eluted with an imidazole gradient and further
puriﬁed by gel ﬁltration using a FPLC system (Puriﬁer Akta – GE
Healthcare). For GST fusion constructs, bacteria were lysed in
50 mM Hepes, 100 mM NaCl, 10 mM EDTA, 10% glycerol, 1% v/v
Triton 100, pH = 7.5 supplemented with DNAse (25 lg/ml) and
Completecocktail (Roche Diagnostic). The lysate was clariﬁed by
centrifugation and loaded on glutathione column (Protino-Glutha-
tione Agarose 4B, Machery-Nagel). For pull-down experiments,
GST-SH3Hck or GST-SH3DOCK domain-loaded glutathione columns
were stored at 4 C with Complete cocktail (Roche diagnostic)
and sodium azide. Overexpressed proteins were tested for their
purity and integrity by gel electrophoresis and when needed by
mass-spectrometry and 1D NMR analysis (quality control NMR
and mass spectrometry facilities, IBS).
2.3. Pull Down experiments using bacterial recombinant constructs
The recombinant 6-His-tagged ELMO1 and GST-SH3Hck or GST-
SH3DOCK constructs were expressed and puriﬁed as described
above. The different ELMO1 domain constructs were incubated
with 50 ll of immobilized GST-SH3Hck or GST-SH3DOCK resins
(1 mg/ml) for one hour at 4 C using the puriﬁcation buffer. The
resin was then washed 3 times with 5 column volumes of the same
buffer. Proteins were eluted in denaturing conditions with 50 ll of
electrophoresis loading buffer. The proteins were separated by
SDS–PAGE and analyzed by western blot using peroxidase
conjugated anti-polyHistidine antibody (Mouse monoclonal
HIS1, Sigma) to reveal the presence of captured 6His-ELMO1
constructs.
2.4. Cell culture, labeling and ﬂow cytometry analysis
HEK293T endothelial cells were maintained in DMEM supple-
mented with 10% (v/v) fetal bovine serum and 1% (v/v) penicillin–
streptomycin. Cells were transiently transfected using Jet Prime
according to the manufacturer’s instruction. Flow cytometry
experiments were performed on a MACSQuant VYB ﬂow cytometer
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experiments, HEK293T were transiently co-transfected with
SNAP-ELMO532–727 or -ELMO532–707 constructs and CLIP-SH3Hck or
with CLIP-SH3Hck alone (control). Cells were labeledwith SNAPOre-
gon green (Ex at 490 nm, Em at 514 nm) and CLIP430 (Ex at 430 nm,
Em at 484 nm) according to the manufacturer instructions (New
England Biolabs™). Cells were eventually ﬁxed with 90% methanol
for 5 min at 20 C and analyzed by ﬂow cytometry. For each
sample, a minimum of 100,000 events was collected. The donor
ﬂuorescence of CLIP430 was acquired in the V1 channel (Ex 405,
Em 450/50 nm) and the acceptor (SNAP Oregon Green) in the B1
channel (Em488, Exc 525/50 nm). The FRET intensitywasmeasured
as the median and standard deviation values of the intensity of the
V2 channel (Ex 405 nm, Em 525/50 nm) after gating of the popula-
tion for transfected cell singlets (FSC-H/A exclusion, FSC-A/SSC-A
homogenous cell population and V1 positive cells) using
MACSQuantify software. The ﬁnal gated population represents
a minimum of 10,000 cells. The percentile of FRET positive cells
is calculated by the ratio of cells with a V2 FRET intensity above
the threshold deﬁned as the median value of the ELMO532–727
transfected assay.
2.5. Pull Down of CLIP-SH3Hck by ELMO1 from cellular extracts
HEK293T cells were transiently transfected with SNAP-ELMO1
domains and CLIP-SH3Hck or with only CLIP-SH3Hck for the con-
trol well. After 48 h, cells were lysed for 30 min at 4 C then cen-
trifuged at 14,000 rpm. The cell lysate was diluted in the
immobilization buffer (50 mM Tris–HCl, 100 mM NaCl, 1 mM
DTT, 0.1% Tween, pH = 7.5), tested for protein expression by
anti-SNAP western-blot analysis (Supplementary Fig. S1), then
incubated with SNAP capture magnetic beads (New England
Biolabs™) for one hour at room temperature. The SNAP-
ELMO1–727 constructs retained by beads due to a covalent bind-
ing were eluted after protease (TEV) cleavage of the SNAP tag
overnight at 4 C. The beads were recovered by contact with a
magnetic rack, and the solubilized fraction is analyzed by west-
ern-blot. The presence of CLIP-SH3Hck retained in case of interac-
tion with ELMO1 domains was detected using an anti SNAP
antibody (New England Biolabs).
2.6. NMR spectroscopy
The chemically-synthesized peptides corresponding to the 28 C-
terminal amino-acids of ELMO1 (ELMO700–727, DLENIQIPDAPPPIP-
KEPSNYDFVYDCN) and its phosphorylated counterpart on tyrosine
720 (ELMO(p)700–727) were commercially obtained (Proteogenix SAS,
France).
For NMR analysis, recombinant 15N labeled GST-SH3Hck was
produced in E. coli harvested in 15N-labeled M9 minimal medium
containing 1 g/L 15NH4Cl and 2 g/L glucose and puriﬁed as
described above. Elution of the SH3 domain of Hck is achieved
after speciﬁc cleavage of the GST tag: the glutathione resin with
immobilized GST-SH3Hck was incubated with PreScission protease
(GE Healthcare) for 4 h at 4 C using the standard protocol provid-
ed by the manufacturer. The uniformly labeled 15N SH3Hck was
then eluted and prepared at a concentration of 1 mg/ml in
50 mM Hepes, 100 mM NaCl, 10 mM EDTA, pH = 7.5. Interactions
between ELMO1 peptides (ELMO700–727 or phosphorylated,
ELMO(p)700–727) and the SH3 domain were investigated by the
addition of aliquots of a concentrated solution of unlabeled
chemically synthesized peptide directly to isotope labeled SH3Hck
to a ﬁnal ratio 1:55.
NMR measurements were performed on Agilent VNMRS
600 MHz or 800 MHz (NMR assignment, SH3 titrationexperiments) systems equipped with cryogenically cooled
triple-resonance probes and pulsed z-ﬁeld gradients. For all
2D-H–N correlation experiments, BEST-TROSY optimized pulse
sequences were used. All NMR data were processed using NMRPipe
[31] and evaluated using NmrViewJ (One Moon Scientiﬁc Inc.).
For the titration experiments, increasing molar ratio of the
ELMO700–727 and ELMO(p)700–727 peptides (up to 55) were obtained
adding aliquots of a peptide solution at either 3 mM (ligand/protein
ratio of 1–5.5) or 30 mM (ligand/protein ratio of 5.5–55) to a
100 lM solution of SH3Hck. Prior to addition, the pH of both peptide
solutions was adjusted to 7.6 using a 1 M NaOH solution. Concen-
tration of ELMO1 peptides was determined by UV–visible spec-
trometry either at 280 nm or 286 nm using a calculated
absorption coefﬁcient at 280 nm of 2980 M1 L1 for ELMO700–727
and a calculated absorption coefﬁcient at 286 nm of 910 M1 L1
for ELMO(p)700–727 [32]. Integrity of the ELMO(p)700–727 peptide
was assessed by mass spectrometry (m/z: 3282.4). 1H and 15N
chemical shift changes were monitored in 2D [1H,15N]-HSQC
spectra at 298 K along the titration. Chemical shift perturbations
were calculated as:
Dd ¼ pððDdHÞ2 þ ½ðcN=cHÞDdN2Þ
Binding constants have been determined from the chemical
shift perturbations of the S95, D110, W112, W113 and S129 resi-
dues which present the greater variations for both peptides, using
in-house modiﬁed non-linear least squares ﬁtting procedures with
Monte-Carlo error analysis from NMRPipe [31] and formula that
take into account the dilution of the protein sample along the
titration [33].
3. Results
Primary studies have suggested that the binding of ELMO1 to
Hck might occur through the interaction between the only
polyproline motif found in the C-terminal tail of ELMO1 and the
SH3 domain of Hck [21]. However, the only data allowing this
assessment are based on competitive experiments between ELMO1
and a known speciﬁc peptide for Src kinases. Moreover, previous
work from our group and others demonstrated that ELMO1 inter-
acts in vitro with the SH3 domain of its ﬁrst identiﬁed binder,
DOCK180, regardless of the presence of the polyproline-containing
C-terminal end. This particularity of the polyproline motif of
ELMO1 and the lack of direct evidence of its binding to Hck, led
us to investigate by direct methods the interaction of ELMO1 with
the isolated SH3 domain of Hck and to compare it to its interaction
with the SH3 domain of DOCK.
3.1. Pull-down with bacterially-expressed recombinant constructs
First, we performed pull-down experiments on immobilized
GST fused SH3 domains of Hck (SH3Hck) or DOCK180 (SH3DOCK)
using different poly-Histidine tagged ELMO1 constructs including
or not the polyproline C-terminal extension (Wild type ELMO1–727
and deletion mutants ELMO532–727 and ELMO532–707, Fig. 1A). The
overexpressed proteins were controlled for their integrity after FPLC
puriﬁcation (Cf. Section 2 and Fig. 1C). As expected, ELMO1–727 is suc-
cessfully pulled-down by both SH3 domains, but not in control
experiments (mock GSH resin, Fig. 1B). As expected from our previ-
ous work, ELMO532–727 and its counterpart lacking the polyproline
extension ELMO532–707, are efﬁciently pulled-down by SH3DOCK. By
contrast, ELMO532–727 is speciﬁcally pulled-down by SH3Hck but
ELMO532–707 is not. These data clearly show that in our experimental
conditions, the interaction between the C-terminal domain of
ELMO1 and the SH3 of Hck is strictly dependent on the presence
of the polyproline motif of ELMO1; a behavior that clearly contrasts
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Fig. 1. Binding of ELMO1 domains on immobilized SH3 domains of Hck and DOCK180. (A) Schematic representation of the different domains of ELMO1: The wild type ELMO1
protein (ELMO1–727), the C-terminal domain with (ELMO532–727) or without the polyproline motif (ELMO532–707) used in this study are indicated. RBD: Rho-Binding Domain;
EID: ELMO Inhibitory Domain; ELMO: ELMO conserved region; PH: Pleckstrin Homology domain; EAD: ELMO Autoregulatory Domain; PxP: Polyproline motif. (B) SH3Hck
binding to ELMO1 is in vitro dependent of ELMO1 polyproline motif, SH3DOCK is not: Recombinant 6His-tagged wild type ELMO1, its various deletion mutants and GST-tagged
SH3 domains of Hck and DOCK180 were bacterially produced and puriﬁed from BL21 (DE3) E. coli. ELMO1 domains were incubated with immobilized either GST-fused
SH3DOCK or SH3Hck and after elution, ELMO1 constructs were detected by anti-6His immuno-western blotting. (C) Coomassie-blue stained gel of the puriﬁed protein
constructs overexpressed in E. Coli: Purity of ELMO and SH3 domains constructs was analyzed after FPLC puriﬁcation by Coomassie-blue stained polyacrylamide gel
electrophoresis in denaturing conditions (12% slab gels). Each construct migrates at its expected apparent molecular weight.
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lacking the polyproline C-terminal motif.
3.2. In cellulo pull-down and Förster resonance energy transfer (FRET)
analysis of ELMO1 and SH3Hck interactions
We next examined if this interaction could occur in the cell con-
text after co-transfection of HEK293T cells. To efﬁciently pull-down
the SH3 domain of Hck, we expressed SNAP-tag and CLIP-tag
[34,35] N-terminal fusion constructs of ELMO1 and SH3Hck, respec-
tively. Lysates of HEK293T cells transiently transfected for the co-
expression of the SH3 domain of Hck in the presence of wild type
ELMO1–727 or the N-terminal deletion mutants ELMO532–727 and
ELMO532–707, were checked for correct protein expression by west-
ern-blot (Supplementary Fig. S1) and subjected to pull-down
experiments using ELMO1 as a bait, taking advantage of the speciﬁc
and covalent binding of SNAP fusion constructs to the SNAP-cap-
ture magnetic beads (New England Biolabs, cf. Section 2). The suc-
cessful pull-down of SH3Hck was assessed by antibody labeling of
the N-terminal CLIP tag of the construct. As shown in Fig. 2 (panel
A), CLIP-SH3Hck is revealed when it is co-expressed with ELMO1–
727 or its C-terminal domain, ELMO532–727. As expected, when
CLIP-SH3Hck is co-expressed with the ELMO1 C-terminal domain
lacking its polyproline motif (ELMO532–707), only a residual signal
similar to the one observed in the negative control (cells transfected
with CLIP-SH3Hck alone) is apparent, despite the correct expression
of CLIP-SH3Hck and ELMO532–707 deletion mutant (Supplementary
Fig. S1). However, a comparable result was observed when mono-
transfected cell lysates were pooled before pull-down (data not
shown), raising the possibility that the interaction could also arise
after cell lysis and not only in the cell context.To ascertain that this interaction occurs within the cell, we per-
formed FRET experiments using the same constructs transiently
expressed in HEK293T epithelial cells. SNAP and CLIP-tag can be
efﬁciently coupled to ﬂuorophores, and have been successfully
used to measure FRET signals in living cells [36]. We used ﬂow
cytometry to analyze the FRET signals of co-transfected or control
HEK293T cell populations. Fig. 2B and C represent a representative
set of the FRET data obtained from independent experiments. In
brief, we calculated the median value of the FRET intensities of
the transfected cells (cf. Section 2 for details). The overlaid
histograms of the FRET intensity of control (dash lines) and co-
transfected (plain lines) cells are shown in Fig. 2B. The cells
co-transfected with SNAP-ELMO532–727 and CLIP-SH3Hck show a
signiﬁcantly higher median FRET intensity compared to control
cells, while any signiﬁcant FRET variation for the cells co-transfect-
ed with SNAP-ELMO532–707 was detected (50% and 8.5% of events
above the threshold respectively, Fig. 2B). Taken together, these
results strongly suggest that the interaction between the C-termi-
nal domain of ELMO1 and the SH3 domain of Hck in the phys-
iological context, requires the presence of the polyproline tail of
ELMO1, further conﬁrming our data obtained on puriﬁed overex-
pressed proteins.
3.3. NMR structural characterization
To characterize the speciﬁc interaction of the SH3 domain of Hck
with the C-terminal polyprolinemotif of ELMO1,wenext investigat-
ed their interaction via NMR spectroscopy. In brief, we studied the
chemical shift mapping variations of this SH3 domain, which have
been 15N labeled, during its titration with increasing amounts of a
synthetic peptide encompassing the polyproline motif (ELMO700–727,
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Fig. 2. Binding of ELMO1 domains to SH3 domain of Hck in the cellular context. (A) SH3Hck binding to ELMO1 is dependent of ELMO1 polyproline motif in co-transfected
HEK293T cell extract: CLIP-SH3Hck was expressed either alone or with SNAP-ELMOWT and its various deletion mutants (ELMO532–727 or ELMO532–707) in HEK293T cells. Cell
lysates were then incubated with SNAP-capture magnetic beads. Proteins were eluted after TEV digestion, separated by SDS–PAGE and the presence of retained CLIP-SH3Hck
by western-blot using a polyclonal antibody anti-SNAP-tag (which is also speciﬁc for CLIP tag). The control well (cells mono-transfected with CLIP-SH3Hck) shows the residual
non-speciﬁc signal. (B) Flow cytometry distribution of FRET intensities of HEK293T cells co-transfected with SH3Hck and ELMO1 deletion mutants: Superposition of the
histograms of the FRET intensities (acceptor ﬂuorescence) from the control cells (transfected with CLIP-SH3Hck, dash line) and cells transfected with CLIP-SH3Hck and either
with SNAP-ELMO532–727 or SNAP-ELMO532–707 (plain lines). The FRET signal was measured in the V2 channel Ex 405 nm, Em 525 ± 25 nm. A shift of the maximum of the
double positive population is observed for the measured FRET channel for SNAP-ELMO532–727 relative to the negative control, while no difference is noticeable for SNAP-
ELMO532–707. The shift is also expressed as the ratio of cells above the threshold in comparison with the total number of cells in the gated region (donor positive cells, see
Section 2). The data shown originate from a single experiment representative of three independent experiments. (C) Bar graph of FRET median values: FRET intensities
median values of the histograms presented in B. The standard deviation errors of the donor positive population are shown.
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15N-SH3Hck in absence (black) or in presence (red) of ELMO700–727,
the titration of SH3Hck resulted in a continuous change of the
chemical shifts of several residues revealing fast exchange kinetics
on the NMR time scale, which is indicative for a comparatively low
binding afﬁnity (Fig. 3A). As illustrated, themajority of induced che-
mical shifts changes are less than 0.05 ppm, which demonstrates
that the overall SH3Hck structure is unchanged. Nonetheless, several
residues present more signiﬁcant variations (>0.05 ppm) of their
resonance peaks upon addition of ELMO700–727 peptide (Fig. 3A, B).
As expected, the amino-acids of SH3Hck affected by the C-terminal
ELMO1 peptide are mainly located in the canonical binding pocket
of SH3 domains for polyproline motifs [37], which is formed by
theRT- andN-Src-loop aswell as theb-strands c andd. Among them,
the following residues showed particularly large chemical shift var-
iations: the canonical aspartic acid D95, serine S110, glutamic acid
E112, tryptophan W113 and serine S129 (Fig. 3B, C).
Additionally, the NMR titration experiment allows determining
the dissociation constant for the SH3Hck/ELMO700–727 complex
formation. The chemical shift changes of the most representative
residues, as deﬁned by the extent of their chemical shift variations
(D95, S110, E112, W113 and S129), were plotted as a function of
the ELMO700–727 concentration (Fig. 4). A global ﬁt of the titration
curves yields a dissociation constant Kd = 1.6 ± 0.3 mM (see
Supplemental Table S1 for details).
This structural characterization further conﬁrms that
the SH3 domain of Hck binds ELMO1 through the polyproline
C-terminal motif, and strongly suggests that the binding
may mimic the canonical binding mode of SH3 domains to
polyproline motifs.4. Discussion
Despite the data accumulated over the past decade, the under-
standing of the ELMO/DOCK pathway regulation in mammalian
cells remains highly entangled. A number of identiﬁed factors, act-
ing as upstream modulators of the ELMO/DOCK GEF activity have
been characterized in a variety of model systems. ELMO1 has been
identiﬁed as a primary binding partner and a target of the tyrosine
kinase Hck in cells of the hematopoietic lineage. In macrophages,
Hck has been suggested to be implicated in the regulation of the
signaling events that are governed by ELMO/DOCK and lead to
actin cytoskeleton regulation [21,38]. It is well established that
phagocytosis depends on tyrosine kinase activity. Indeed, the
functions of several receptors implicated in phagocytosis or migra-
tion, such as TAMs [39] or CD36 [40] have been demonstrated to
rely on phosphorylation of tyrosine residues [5,41]. The recruit-
ment of the p130cas–CrkII–DOCK180 complex during apoptotic
cell clearance is triggered by a yet unidentiﬁed tyrosine kinase in
the avb5 integrin pathway [42]. Furthermore, phagocytosis mediat-
ed by Fcc receptor is largely regulated by kinases of the Src family
[43] and it has also been shown that speciﬁc inhibition of the
Src family kinase by PP2 decreases phagocytosis efﬁciency in
macrophages [44].
In the present work, we have provided several lines of evidence
showing that ELMO1 interacts with the SH3 domain of Hck
through its C-terminal polyproline motif. Using puriﬁed protein
domains we have demonstrated that, in contrast with the binding
of the SH3 domain of DOCK180, Hck interaction is strictly depen-
dent on the C-terminal polyproline motif of ELMO1. The charac-
terization of this interaction using a synthetic polyproline
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Fig. 4. The interaction between the SH3 domain of Hck and the polyproline motif of
ELMO1 is of moderate afﬁnity. Titration of the 15N-labeled SH3 domain of Hck with
increasing amounts of the ELMO707–727 peptide (up to 55 equivalents). The titration
curves result from the ﬁtting of the chemical shift variations of the aspartate 95,
serine 110 and 129, tryptophan 113 and the glutamate 112 as a function of the
ELMO707–727 peptide concentration. These variations were measured for the ﬁve
different residues and the dissociation constant was calculated as described in the
Section 2.
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ciation constant of 1.6 ± 0.3 mM. The speciﬁc residues of the SH3
domain of Hck affected by the binding are highly correlated to
the residues implicated in its well characterized binding with the
PD1 model polyproline peptide [37], further reinforcing the fact
that SH3Hck binding to ELMO1 polyproline is archetypical in nature.
Still, the molecular interaction between the C-terminal peptide of
ELMO1 and the SH3 domain of Hck appears to be of modest afﬁnity
compared to polyproline/SH3 domain bindings commonly-found
for Hck. However, preliminary solid-phase enzyme immunoassay
data obtained in the presence of ELMO532–727 show that the disso-
ciation rate of SH3Hck is in the ten-micromolar range (data not
shown). This observation suggests that in the context of the integer
protein, the ELMO1/Hck interaction may be of higher afﬁnity and
may involve other regions of ELMO1 in the complex formation.
The set of data that we are providing thus implies that the ELMO1
polyproline/SH3Hck interaction likely contributes to the kinase
speciﬁcity towards ELMO1 and to the recruitment of Hck by
ELMO1 or vice versa during DOCK protein regulation and Rac1
activation.
Nevertheless, the physiological consequences of the interaction
of the SH3 domain of Hck with ELMO1 polyproline motif remain
today an open question. SH3 domains in kinases of the Src family
are known to participate in the kinase activity regulation and
speciﬁcity [45,46]. More than triggering DOCK GEF activity through
R. Awad et al. / FEBS Open Bio 5 (2015) 99–106 105ELMO1 as suggested before, one possible outcome of Hck/ELMO1
complex formation would be also the activation or activity regula-
tion of Hck upon ELMO1 binding. Indeed, ELMO1 is phosphorylated
by Hck on ﬁve identiﬁed tyrosines (residues 18, 216, 395, 511 and
720) [38] and using non-phosphorylatable mutants, Yokoyama and
collaborators reported that phosphorylation is not required for
ELMO1/DOCK180 complex formation, although it contributes
synergistically to Rac1 activation and increases phagocytosis
efﬁciency and migration of LR73 ﬁbroblasts. The authors showed
that tyrosine 511 to phenylalanine mutation drastically reduces
phagocytosis efﬁciency, whereas tyrosine 720 to phenylalanine
mutation does not. In contrast, Abu-Thuraia and collaborators
recently demonstrated that ELMO2 tyrosine 713 phosphorylation
(equivalent to tyrosine 720 in ELMO1) by the receptor tyrosine
kinase Axl promotes cell invasion in MDA-MB-231 breast cancer
cells [5]. Intriguingly, tyrosine 720 stands within the polyproline
motif of ELMO1. We thus addressed the question of the inﬂuence
of the phosphorylation of tyrosine 720 on ELMO1 polyproline bind-
ing to the SH3 domain of Hck. Using the phosphorylated counter-
part of the polyproline motif containing peptide ELMO700–727, we
measured the chemical shifts variations during the titration of
the 15N labeled recombinant SH3 domain of Hck. When comparing
the side chains of SH3 affected by the binding of the phosphorylat-
ed ELMO(p)700–727 or of the non-phosphorylated form, we observed
that the same residues were affected, indicating that the binding
site is not speciﬁcally altered by tyrosine 720 phosphorylation
(data not shown). Hence, the chemical shifts experienced lower
variations for the phosphorylated peptide at similar pep-
tide:HckSH3 ratios. A global ﬁt of the variations of the same
representative residues as a function of the increased ratio
ELMO(p)700–727:HckSH3 yields a higher dissociation constant
Kd = 5 ± 1.5 mM (Fig. 5 and Table S1), signiﬁcantly different from
the Kd for the non-phosphorylated peptide (Kd = 1.6 ± 0.3 mM),
thus indicating that phosphorylation of tyrosine 720 may weaken
the ELMO1/Hck binding. Previously published work by Yokoyama
and collaborators shows that tyrosine 720 mutation to phenylala-
nine results in an apparent overall increased phosphorylation of
the remaining target tyrosines of ELMO1 expressed in Cos7 cells
[38]. It is well established that the SH3 domain interaction of the
kinases of the Src family is implicated in the kinase activity regula-ELMO(p)707-727
ELMO707-727
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Fig. 5. Comparison of the interaction between the SH3 domain of Hck and the
phosphorylated or the non-phosphorylated polyproline motif of ELMO1. Titration of
the 15N-labeled SH3 domain of Hck with increasing amounts of the phosphorylated
ELMO(p)707–727 peptide (open squares) or of the non-phosphorylated ELMO707–727
peptide (open circles). The titration curves of the chemical shift variations of the
representative tryptophan 113 side chain are compared as a function of the
peptides concentrations (up to 55 equivalents). These variations were measured for
at least ﬁve different residues and the dissociation constant was calculated as
described in the Section 2.tion [47]. It is then tempting to speculate that the observed
decreased afﬁnity of phosphorylated ELMO1 tail for Hck SH3
domain might in turn participate in the down-regulation of the
kinase. Taken together, the present results suggest that the
polyproline of ELMO1 might act as a putative modulator of Hck
activity towards ELMO1 that in turn participates, by a yet unknown
mechanism, to DOCK180 activation and further triggers Rac1 GTP
loading. Interestingly, tyrosine 720 of ELMO1 has been recently
demonstrated to be phosphorylated by the Mer related receptor
tyrosine kinase Axl [5]. This new study and the illustrated role of
members of the TAMs family in apoptotic corpses clearance
[39,48] suggest that ELMO1 might also be a physiological target
of Mer during phagocytosis. These recent results and our present
data emphasize the role of ELMO C-terminal tail, and in particular
its tyrosine and its phosphorylation, in the modulation of the
downstream signaling cascade leading to actin remodeling via
DOCK proteins, a role that remains to be further clariﬁed.Author contributions
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